We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.4B
AUM Growth
+$3.53B
(+32%)
Cap. Flow
+$2.81B
Cap. Flow
% of AUM
19.5%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
1,820
New
468
Increased
1,221
Reduced
109
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$160M |
| 2 |
Microsoft
MSFT
|
+$116M |
| 3 |
Amazon
AMZN
|
+$84.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$71.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$57.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$62.3M |
| 2 |
KITE
Kite Pharma, Inc.
KITE
|
+$6.62M |
| 3 |
VF Corp
VFC
|
+$4.38M |
| 4 |
W.W. Grainger
GWW
|
+$3.97M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$3.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.64% |
| 2 | Financials | 14.34% |
| 3 | Healthcare | 13.98% |
| 4 | Consumer Staples | 10.45% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Lexicon Pharmaceuticals
LXRX
$1.02B
| $625K | ﹤0.01% |
63,281
+851
| +1% | +$8.84K |
|
1027
Cabot Corp
CBT
$4.65B
| $623K | ﹤0.01% |
10,123
+2,416
| +31% | +$145K |
|
|
JBTM
1028
JBT Marel
JBTM
$7.14B
| $623K | ﹤0.01% |
5,623
+2,850
| +103% | +$311K |
|
1029
Deckers Outdoor
DECK
$13.3B
| $618K | ﹤0.01% |
46,200
+19,962
| +76% | +$239K |
|
1030
Prestige Consumer Healthcare
PBH
$2.35B
| $618K | ﹤0.01% |
13,927
+5,621
| +68% | +$256K |
|
1031
AXIS Capital
AXS
$8.59B
| $615K | ﹤0.01% |
12,227
+695
| +6% | +$37K |
|
|
CVSA
1032
Covista Inc
CVSA
$3.94B
| $611K | ﹤0.01% |
14,539
+5,946
| +69% | +$233K |
|
1033
Worthington Enterprises
WOR
$2.76B
| $611K | ﹤0.01% |
22,508
+8,569
| +61% | +$229K |
|
|
LMNX
1034
DELISTED
Luminex Corp
LMNX
| $611K | ﹤0.01% |
31,037
+2,611
| +9% | +$54.3K |
|
1035
Selective Insurance
SIGI
$5.74B
| $609K | ﹤0.01% |
10,375
+5,219
| +101% | +$302K |
|
1036
Genworth Financial
GNW
$3.8B
| $605K | ﹤0.01% |
194,650
+55,038
| +39% | +$190K |
|
1037
Teledyne Technologies
TDY
$30.4B
| $604K | ﹤0.01% |
3,337
+909
| +37% | +$160K |
|
1038
United Natural Foods
UNFI
$3.01B
| $604K | ﹤0.01% |
12,250
+5,201
| +74% | +$227K |
|
1039
Vipshop
VIPS
$6.84B
| $604K | ﹤0.01% |
+51,551
| New | +$456K |
|
1040
Amphastar Pharmaceuticals
AMPH
$825M
| $601K | ﹤0.01% |
31,232
+2,025
| +7% | +$37.8K |
|
1041
Credit Acceptance
CACC
$6B
| $601K | ﹤0.01% |
1,857
+109
| +6% | +$32.4K |
|
1042
Teradata
TDC
$2.68B
| $601K | ﹤0.01% |
15,638
+3,256
| +26% | +$116K |
|
|
WDR
1043
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $601K | ﹤0.01% |
26,924
+8,043
| +43% | +$164K |
|
|
FNGN
1044
DELISTED
Financial Engines, Inc.
FNGN
| $601K | ﹤0.01% |
19,841
+5,925
| +43% | +$186K |
|
1045
Commault Systems
CVLT
$5.89B
| $600K | ﹤0.01% |
11,434
+4,614
| +68% | +$255K |
|
1046
NewMarket
NEU
$7.17B
| $600K | ﹤0.01% |
1,509
+366
| +32% | +$148K |
|
1047
Insulet
PODD
$11.3B
| $596K | ﹤0.01% |
8,632
+4,636
| +116% | +$304K |
|
|
DISCK
1048
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $593K | ﹤0.01% |
28,012
-60,893
| -68% | -$1.12M |
|
1049
Granite Construction
GVA
$5.45B
| $592K | ﹤0.01% |
9,336
+4,067
| +77% | +$254K |
|
|
B
1050
DELISTED
Barnes Group Inc.
B
| $590K | ﹤0.01% |
9,319
+4,687
| +101% | +$311K |
|
Similar funds
ProShare Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, ProShare Advisors held 1,820 positions worth $14.4B, up 32% from $10.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors deployed $2.81B of net new capital in Q4 2017, opening 468 new positions and adding to 1,221 existing holdings. Its largest new stake was ASML: 31,220 shares worth $5.43M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VF Corp, an estimated $4.38M trimmed.
- ProShare Advisors's largest Q4 2017 buy was ASML: 31,220 shares worth $5.43M.
- ProShare Advisors added most to Apple in Q4 2017, an estimated $160M increase.
- ProShare Advisors's biggest Q4 2017 reduction was VF Corp, cutting an estimated $4.38M.
- ProShare Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.3M.
- ProShare Advisors's ten largest holdings make up 18% of its $14.4B portfolio in Q4 2017.
- ProShare Advisors opened 468 new positions and closed 21 in Q4 2017.
- ProShare Advisors's portfolio value rose 32% quarter-over-quarter to $14.4B.
Based on ProShare Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.